Re: Why now?
in response to
by
...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!
Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials
Message: Re: Why now?
Your Vote:
Did you know?
You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)
I have e-trade, mine were recently valued at $0.475 and were shown as being recently traded(not my shares, but shares of ZHCLF). I tried to buy more via e-trade and was denied. TD Waterhouse also denied my friend to buy.
3 Recommendations
Loading...
Loading...
New Message
Please
login
to post a reply